Archives of Medical Research
Volume 35, Issue 6 , Pages 540-545 , November 2004

Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lp(a) levels according to thyroid function status

  • Won-Young Lee

      Affiliations

    • Equal contributions.
    • Corresponding Author InformationAddress reprint requests to: Won-Young Lee, MD, PhD. Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, #108 Pyung-Dong, Jongro-Ku, Seoul 110-746, Korea. Tel: 82-2-2001-2075, Fax: 82-2-2001-2049
    • ,
  • Jung-Yul Suh

      Affiliations

    • Equal contributions.
    • ,
  • Eun-Jung Rhee
    • ,
  • Jeong-Sik Park
    • ,
  • Ki-Chul Sung
    • ,
  • Sun-Woo Kim

Received 2 March 2004 ,Accepted 28 July 2004.

References 

  1. Stone NJ. Secondary causes of hyperlipidemia. Med Clin North Am. 1994;78:117–141
  2. Caron PH, Calazel C, Parra HJ, Hoff M, Louvet JP. Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin Endocrinol. 1990;33:519–523
  3. Bogner U, Arntz HR, Peters H, Schleusener H. Subclinical hypothyroidism and hyperlipoproteinemia: indiscriminate L-thyroxine treatment not justified. Acta Endocrinol. 1993;128:202–206
  4. Tulloch BR, Lewis B, Fraser BR. Triglyceride metabolism in thyroid disease. Lancet. 1973;1:391–394
  5. Walto KW, Scott PJ, Kykes PW, Davis JWC. The significance of alteration in serum lipids in thyroid dysfunction. Alterations of the metabolism and turnover of 131I low density lipoproteins in hypothyroidism and thyrotoxicosis. Clin Sci. 1965;29:217–223
  6. Krishna GS, Hynie S, Brodie B. Effects of thyroid hormone on adenyl cyclase in adipose tissue and on fatty acid mobilization. Proc Natl Acad Sci. 1968;59:884–889
  7. Tada JR, Widnell CC. Ribonucleic acid synthesis during the early action of thyroid hormone. J Biochem. 1966;98:604–620
  8. Nikkila EA, Kekki M. Plasma triglyceride metabolism in thyroid disease. J Clin Invest. 1972;51:2103–2114
  9. Garfinkel AS, Baker N, Schotz MC. Relationship of lipoprotein lipase activity to triglyceride uptake in adipose tissue. J Lipid Res. 1967;8:274–280
  10. Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation. 1997;96:4204–4210
  11. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165–2168
  12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  13. Kutty KM, Bryant DG, Farid NR. Serum lipids in hypothyroidism—a re-evaluation. J Clin Endocrinol Metab. 1978;46:55–56
  14. Mutai A, Miyhara T, Fujimoto M, Matsuda M, Karneyama M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis. 1986;59:199–204
  15. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987;300:132–137
  16. Genest J, Jenner JL, McNamara JR, Ordovas JM, Silberman SR, Wilson PW, et al. Prevalence of lipoprotein(a) excess in coronary artery disease. Am J Cardiol. 1991;67:1039–1045
  17. Caraccio N, Ferrannini E, Monzani F. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab. 2002;87:1533–1538
  18. Kussi T, Taskinen MR, Nikkila EA. Lipoprotein, lipolytic enzymes and hormonal status in hypothyroid women at different levels of substitution. J Clin Endocrinol Metab. 1988;66:51–56
  19. Utermann G. The mysteries of lipoprotein (a). Science. 1989;246:904–910
  20. Takeda I. Emergency laboratory service in Shinane prefectural central hospital. Jpn J Clin Pathol. 1981;29:37–41
  21. Thompson SG, Fechtrup C, Squire E, Heyse U, Breithardt G, van de Loo JC, et al. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris. Arterioscler Thromb Vasc Biol. 1996;16:357–362
  22. Anderson JL, Carlquist JF, Muhlestein JB, Horne BD, Elmer SP. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol. 1998;32:35–41
  23. Libby P, Ridker PM. Novel inflammatory markers of coronary risk. Circulation. 1999;100:1148–1150
  24. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996;312:1061–1065
  25. Yla-Herttuala S. Oxidized LDL and atherogenesis. Ann N Y Acad Sci. 1999;874:134–137
  26. Strandberg TE, Vanhanen H, Tikkanen MJ. Associations between change in C-reactive protein and serum lipids during statin treatment. Ann Med. 2000;32:579–583
  27. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation. 1999;100:793–798
  28. Sattar N, Perera M, Small M, Lumsden MA. Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes. Lancet. 1999;354:487–488
  29. Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, et al. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis. 2003;166:379–386
  30. Azizi F, Raiszadeh F, Solati M, Etemadi A, Rahmani M, Arabi M. Serum paraoxonase 1 activity is decreased in thyroid dysfunction. J Endocrinol Invest. 2003;26:703–709
  31. Raiszadeh F, Solati M, Etemadi A, Azizi F. Serum paraoxonase activity before and after treatment of thyrotoxicosis. Clin Endocrinol. 2004;60:75–80

 This study was supported by a Samsung grant (No. SBRI C-A3-223-1).

PII: S0188-4409(04)00100-6

doi: 10.1016/j.arcmed.2004.08.003

Archives of Medical Research
Volume 35, Issue 6 , Pages 540-545 , November 2004

Article Tools